Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Firms Criticize FDA Proposals To Share More Pre-Market Intel

This article was originally published in The Gray Sheet

Executive Summary

Device and drug makers say FDA's draft proposals for publicly releasing more information on product applications would cripple the industry without providing much benefit to patients

You may also be interested in...



Regulatory News In Brief

FDA downclassifies tissue adhesives for wound closure

Regulatory News In Brief

FDA downclassifies tissue adhesives for wound closure

FDA Unveils 21 Policy Changes To Increase Transparency With Public

FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency

Related Content

Topics

UsernamePublicRestriction

Register

MT029163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel